| Literature DB >> 26719826 |
Abstract
Introduction Bodily isomerism, also known as heterotaxy, is a unique entity in which there is mirror imagery in various organ systems. Those with isomerism will often have congenital malformations of the heart requiring functionally univentricular palliation. Anecdotally, thrombocytosis has been noted with higher frequency in patients with isomerism. This study aimed to determine the prevalence of thrombocytosis at different stages and identify independent predictors of thrombocytosis. Methods We identified patients with isomerism and a functionally univentricular heart who received care at our institution between January 1998 and January 2014. Clinical data regarding these patients was collected via chart review. Platelet counts were collected before initial surgical palliation, the day prior to second surgical palliation, and the day prior to the third surgical palliation. Platelet counts from the first postoperative day following all three surgical palliations was also collected. Mean platelet counts were compared between consecutive stages as well as to the initial platelet count. The frequency of thrombocytosis was also calculated at each point with a binomial logistic regression conducted to determine independent risk factors of thrombocytosis at each time point. Results A total of 57 patients were included in the analysis. The mean platelet count before initial surgical palliation was 349.21 x 10(9)/L and decreased with age. Thrombocytosis was noted in 15.8% prior to initial surgical palliation and 23.6% prior to second surgical palliation. Thrombocytosis was no longer noted after second surgical palliation. No independent risk factors for thrombocytosis were identified. Conclusion Thrombocytosis is not infrequent during the first year of life in those with isomerism. It is important to be vigilant of platelet counts in this population as thrombocytosis may lead to increased thromboembolic events, particularly in the setting of a Blalock-Taussig shunt. Thrombocytosis nearly always resolves after the second surgical palliation.Entities:
Keywords: heterotaxy; isomerism; platelet; single ventricle; thrombocytosis; univentricular
Year: 2015 PMID: 26719826 PMCID: PMC4689566 DOI: 10.7759/cureus.383
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Overall characteristcs
Patient characteristics for those included in the analysis
| Characteristic | Frequency (Percent) or Median (Minimum to Maximum) |
| Total number | 57 |
| Male | 31 (54.5) |
| Common atrioventricular junction | 39 (68.4) |
| Double outlet right ventricle | 27 (47.4) |
| Double inlet left ventricle | 1 (1.8) |
| Left sided superior caval vein | 34 (59.6) |
| Bilateral superior caval veins | 29 (50.9) |
| Interrupted inferior caval vein | 12 (21.1) |
| Discordant ventriculoarterial connections | 14 (24.6) |
| Splenic anatomy | |
| Absence of a spleen | 42 (73.7) |
| Multiple spleens | 8 (14.0) |
| Solitary spleen | 6 (10.5) |
| Data not available | 1 (1.8) |
| Evaluation for intestinal malrotation | 38 (66.7) |
| Intestinal malrotation | 24 (43.9) |
| Surgery for intestinal malrotation | 23 (40.4) |
| Morphology of the atrial appendages by inference | |
| Left | 17 (29.8) |
| Right | 40 (70.2) |
| Bronchial morphology | |
| Left | 5 (8.8) |
| Right | 45 (78.9) |
| Imaging not available to determine | 7 (12.3) |
| Abdominal situs | |
| Right sided liver, left-sided stomach | 19 (33.3) |
| Left sided liver, right-sided stomach | 13 (22.8) |
| Midline liver with right or left-sided stomach | 13 (22.8) |
| Data not available | 4 (7.0) |
| Arrhythmia | 24 (42.1) |
| Need for pacemaker | 6 (10.5) |
| Need for extracorporeal membrane oxygenation | 7 (12.3) |
| Episode of documented bacteremia | 11 (19.3) |
| Prenatal diagnosis | 39 (68.4) |
| Age at initial surgical palliation (n=53) | 9 days (0 days to 2.7 years) |
| Age at second surgical palliation (n=48) | 6.4 months (13 days to 11 years) |
| Age at third surgical palliation (n=21) | 3.3 years (0.5 years to 15 years) |
| Mortality | 14 (24.6) |
| Age at death | 3.42 years (1 day to 23 years) |
Platelet counts
Mean platelet count for at each time point
†Significant difference between this value and value immediately preceding this
‡Significant difference between this value and the value before stage 1
| Platelet count before first palliation | Platelet count after first palliation | Platelet count before second palliation | Platelet count after second palliation | Platelet count before third palliation | Platelet count after third palliation | Platelet count late after third palliation |
| 349.21 ± 149.28 | 248.63 ± 126.48† | 422.03 ± 135.54† | 217.13 ± 103.74† | 351.36 ± 77.79† | 180.68 ± 73.83† | 264.12 ± 113.39† |
Univariate analysis
Univariate analysis to identify characteristics associated with thrombocytosis before second palliation
| No Thrombocytosis Before Second Palliation (n=29) | Thrombocytosis Before Second Palliation (n=9) | Odds Ratio (95% Confidence Interval) | |
| Atrioventricular septal defect | 19 (65.5) | 5 (55.6) | 0.658 (0.144 to 3.013) |
| Double outlet right ventricle | 17 (58.6) | 5 (55.6) | 0.882 (0.195 to 3.987) |
| Double inlet left ventricle | 0 (0) | 0 (0) | -- |
| Bilateral superior caval vein | 15 (51.7) | 4 (44.4) | 0.747 (0.166 to 3.357) |
| Left superior caval vein | 18 (62.1) | 5 (55.6) | 0.833 (0.164 to 3.425) |
| Interrupted inferior caval vein | 6 (20.7) | 1 (11.1) | 0.479 (0.050 to 4.614) |
| Discordant atrioventricular connections | 3 (10.3) | 3 (33.3) | 4.34 (0.780 to 6.948) |
| Discordant ventriculoarterial connections | 7 (24.1) | 1 (11.1) | 0.393 (0.046 to 4.214) |
| Anomalous pulmonary venous connection | 12 (43.3) | 1 (11.1) | 0.177 (0.024 to 0.956) |
| Splenic anatomy | |||
| Absence of spleen | 19 (65.5) | 9 (100.0) | -- |
| Multiple spleens | 5 (17.2) | 0 (0) | -- |
| Solitary, normally located spleen | 5 (17.2) | 0 (0) | -- |
| Atrial appendage morphology | |||
| Right | 20 (69.0) | 7 (77.8) | -- |
| Left | 9 (31.0) | 2 (22.2) | -- |
Platelet counts
Mean platelet count at each time for those who had thrombocytosis prior to initial surgical palliation
†Significant difference between this value and value immediately preceding this
‡Significant difference between this value and the value before Stage 1
| Platelet count before initial palliation | Platelet count after initial palliation | Platelet count before second palliation | Platelet count after second palliation | Platelet count before third palliation | Platelet count after third palliation | Platelet count late after third palliation |
| 607.40 ± 105.26 | 331.20 ± 125.14† | 452.20 ± 122.63 | 193.00 ± 81.25† | 355.67 ± 83.20† | 196.33 ± 40.15 | 288.33 ± 163.30 |
Univariate analysis
Univariate analysis to idnetify chracteristics associated with thrombocytosis prior to iniital surgical palliation
| No Thrombocytosis Before Initial Palliation (n=48) | Thrombocytosis Before Initial Palliation (n=9) | Odds Ratio (95% Confidence Interval) | p-value |
| 34 (70.4) | 4 (40.0) | 0.281 (0.039 to 2.014) | 0.189 |
| 23 (48.1) | 3 (60.0) | 1.615 (0.232 to 11.263) | 0.626 |
| 0 (0) | 0 (0) | -- | -- |
| 30 (63.0) | 1 (20.0) | 0.147 (0.014 to 1.506) | 0.075 |
| 34 (70.4) | 2 (40.0) | 0.281 (0.039 to 2.014) | 0.189 |
| 9 (18.5) | 1 (20.0) | 1.100 (0.100 to 12.087) | 0.938 |
| 11 (22.2) | 1 (20.0) | 1.090 (0.084 to 11.457) | 0.908 |
| 12 (25.9) | 0 (0) | -- | 0.372 |
| 23 (48.1) | 3 (60.0) | 1.615 (0.232 to 11.263) | 0.626 |
| 37 (77.8) 4 (7.4) 7 (14.8) | 5 (100.0) 0 (0) 0 (0) | -- -- -- | 0.505 |
| 37 (77.8) 11 (22.2) | 2 (40.0) 3 (60.0) | -- -- | 0.399 |